These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 33511041)
1. Hereditary hemorrhagic telangiectasia presenting as a recurrent epistaxis in an adolescent: A case report. Acharya R; Portwood K; Upadhyay K World J Clin Pediatr; 2021 Jan; 10(1):1-6. PubMed ID: 33511041 [TBL] [Abstract][Full Text] [Related]
2. Hereditary hemorrhagic telangiectasia in a 42-year-old Ethiopian man presenting with severe anemia and high-output heart failure: A case report with literature review. Solela G; Adamseged M; Mohammed A Clin Case Rep; 2023 Jul; 11(7):e7694. PubMed ID: 37448947 [TBL] [Abstract][Full Text] [Related]
5. [Bevacizumab: a new success in hereditary hemorrhagic telangiectasia]. Bennesser Alaoui H; Lehraiki M; Hamaz S; El Attar N; Fakhreddine N; Serraj K Rev Med Interne; 2015 Sep; 36(9):623-5. PubMed ID: 25595875 [TBL] [Abstract][Full Text] [Related]
6. Topical application of timolol decreases the severity and frequency of epistaxis in patients who have previously undergone nasal dermoplasty for hereditary hemorrhagic telangiectasia. Ichimura K; Kikuchi H; Imayoshi S; Dias MS Auris Nasus Larynx; 2016 Aug; 43(4):429-32. PubMed ID: 26739947 [TBL] [Abstract][Full Text] [Related]
7. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia. Mahoney EJ; Shapshay SM Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial. Dupuis-Girod S; Pitiot V; Bergerot C; Fargeton AE; Beaudoin M; Decullier E; Bréant V; Colombet B; Philouze P; Faure F; Letievant JC Sci Rep; 2019 Aug; 9(1):11986. PubMed ID: 31427745 [TBL] [Abstract][Full Text] [Related]
10. Hereditary hemorrhagic telangiectasia. Kamath N; Bhatia S; Singh H; Shetty A; Shetty S N Am J Med Sci; 2015 Mar; 7(3):125-8. PubMed ID: 25839006 [TBL] [Abstract][Full Text] [Related]
11. [Research progress of bevacizumab in the treatment of refractory epistaxis caused by hereditary hemorrhagic telangiectasia]. Xu C; Wang HT Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 51(6):476-9. PubMed ID: 27345893 [TBL] [Abstract][Full Text] [Related]
12. Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia. Gonzalez CD; Mcdonald J; Stevenson DA; Whitehead KJ; Petersen MG; Presson AP; Ding Q; Wilson KF Laryngoscope; 2018 Jul; 128(7):1714-1719. PubMed ID: 29171658 [TBL] [Abstract][Full Text] [Related]
13. Free-flap reconstruction for the management of life-threatening hereditary hemorrhagic telangiectasia. Choi JW; Joo YH; Jeong WS; Jang YJ Auris Nasus Larynx; 2017 Oct; 44(5):607-611. PubMed ID: 27616747 [TBL] [Abstract][Full Text] [Related]
14. Endoscopic cryotherapy for the treatment of epistaxis due to hereditary hemorrhagic telangiectasia. Kim JY; Oh JH; Kim GT; Kwon JH J Craniofac Surg; 2014; 25(2):e120-2. PubMed ID: 24469376 [TBL] [Abstract][Full Text] [Related]
16. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu). Hanks JE; Hunter D; Goding GS; Boyer HC Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220 [TBL] [Abstract][Full Text] [Related]
17. Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia. Al-Samkari H; Kritharis A; Rodriguez-Lopez JM; Kuter DJ J Intern Med; 2019 Feb; 285(2):223-231. PubMed ID: 30191646 [TBL] [Abstract][Full Text] [Related]
18. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients. Pagella F; Colombo A; Matti E; Giourgos G; Tinelli C; Olivieri C; Danesino C Am J Rhinol Allergy; 2009; 23(1):52-8. PubMed ID: 19379613 [TBL] [Abstract][Full Text] [Related]
19. Septectomy and septal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia and septal perforation. Lesnik GT; Ross DA; Henderson KJ; Joe JK; Leder SB; White RI Am J Rhinol; 2007; 21(3):312-5. PubMed ID: 17621815 [TBL] [Abstract][Full Text] [Related]
20. Treatment of Hereditary Hemorrhagic Telangiectasia-Related Epistaxis. Sautter NB; Smith TL Otolaryngol Clin North Am; 2016 Jun; 49(3):639-54. PubMed ID: 27267016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]